Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer

被引:2
|
作者
Herold, Alexander [1 ]
Wassipaul, Christian [1 ]
Weber, Michael [1 ]
Lindenlaub, Florian [1 ]
Rasul, Sazan [1 ]
Stift, Anton [2 ]
Stift, Judith [3 ,4 ]
Mayerhoefer, Marius E. [1 ,5 ]
Hacker, Marcus [1 ]
Ba-Ssalamah, Ahmed [1 ]
Haug, Alexander R. [1 ,6 ]
Tamandl, Dietmar [1 ]
机构
[1] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Gen Surg, Vienna, Austria
[3] Med Univ Vienna, Dept Pathol, Vienna, Austria
[4] INNPATH GmbH, Tirolkliniken, Innsbruck, Austria
[5] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA
[6] Med Univ Vienna, Christian Doppler Lab Appl Metabol, Vienna, Austria
关键词
PET; MRI; MR; Rectal cancer; Staging; DIFFUSION-WEIGHTED MRI; COLORECTAL-CANCER; PREOPERATIVE CHEMORADIOTHERAPY; OPEN-LABEL; CHEMOTHERAPY; RADIOTHERAPY; SOCIETY;
D O I
10.1007/s00259-022-05936-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The purpose of this study was to determine whether multiparametric positron emission tomography/magnetic resonance imaging (mpPET/MRI) can improve locoregional staging of rectal cancer (RC) and to assess its prognostic value after resection. Methods: In this retrospective study, 46 patients with primary RC, who underwent multiparametric 18F-fluorodeoxyglucose (FDG) PET/MRI, followed by surgical resection without chemoradiotherapy, were included. Two readers reviewed T- and N- stage, mesorectal involvement, sphincter infiltration, tumor length, and distance from anal verge. In addition, diffusion-weighted imaging (DWI) and PET parameters were extracted from the multiparametric protocol and were compared to radiological staging as well as to the histopathological reference standard. Clinical and imaging follow-up was systematically assessed for tumor recurrence and death. Results: Locally advanced rectal cancers (LARC) exhibited significantly higher metabolic tumor volume (MTV, AUC 0.74 [95% CI 0.59-0.89], p = 0.004) and total lesion glycolysis (TLG, AUC 0.70 [95% CI 0.53-0.87], p = 0.022) compared to early tumors. T-stage was associated with MTV (AUC 0.70 [95% CI 0.54-0.85], p = 0.021), while N-stage was better assessed using anatomical MRI sequences (AUC 0.72 [95% CI 0.539-0.894], p = 0.032). In the multivariate regression analysis, depending on the model, both anatomical MRI sequences and MTV/TLG were capable of detecting LARC. Combining anatomical MRI stage and MTV/TLG led to a superior diagnostic performance for detecting LARC (AUC 0.81, [95% CI 0.68-0.94], p < 0.001). In the survival analysis, MTV was independently associated with overall survival (HR 1.05 [95% CI 1.01-1.10], p = 0.044). Conclusion: Multiparametric PET-MRI can improve identification of locally advanced tumors and, hence, help in treatment stratification. It provides additional information on RC tumor biology and may have prognostic value.
引用
收藏
页码:205 / 217
页数:13
相关论文
共 50 条
  • [21] Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer
    Sanli, Yasemin
    Zukotynski, Katherine
    Mittra, Erik
    Chen, Delphine L.
    Nadel, Helen
    Niederkohr, Ryan D.
    Subramaniam, Rathan M.
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (12) : E439 - E452
  • [22] Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
    Mistry, Vijay
    Scott, Justin R. R.
    Wang, Tzu-Yang
    Mollee, Peter
    Miles, Kenneth A. A.
    Law, W. Phillip
    Hapgood, Greg
    CANCER IMAGING, 2023, 23 (01)
  • [23] Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
    Schaarschmidt, Benedikt M.
    Grueneisen, Johannes
    Heusch, Philipp
    Gomez, Benedikt
    Umutlu, Lale
    Ruhlmann, Verena
    Rosenbaum-Krumme, Sandra
    Antoch, Gerald
    Buchbender, Christian
    NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (06) : 588 - 595
  • [24] [18F]FDG PET/MRI in rectal cancer
    Filippo Crimì
    Silvia Valeggia
    Luca Baffoni
    Roberto Stramare
    Carmelo Lacognata
    Gaya Spolverato
    Laura Albertoni
    Alessandro Spimpolo
    Laura Evangelista
    Pietro Zucchetta
    Diego Cecchin
    Salvatore Pucciarelli
    Annals of Nuclear Medicine, 2021, 35 : 281 - 290
  • [25] The Performance Comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for the Identification of Pancreatic Neoplasms
    Xing, Haiqun
    Ding, Haiyan
    Hou, Bo
    Hao, Zhixin
    Hu, Ya
    Zhu, Wenjia
    Liang, Sayuan
    Feng, Feng
    Li, Fang
    Zhao, Yupei
    Huo, Li
    MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (03) : 489 - 497
  • [26] Added value of 18F-FDG PET-CT in staging of Ewing sarcoma in children and young adults
    Johnsen B.
    Fasmer K.E.
    Boye K.
    Rosendahl K.
    Trovik C.
    Biermann M.
    Aukland S.M.
    European Journal of Hybrid Imaging, 2 (1):
  • [27] 18F-FDG PET for staging and monitoring of solitary plasmacytoma
    Adib, S.
    Leleu, X.
    Robu, D.
    Huglo, D.
    Steinling, M.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2010, 34 (02): : 88 - 95
  • [28] The added value of 18F-FDG PET/MRI multimodal imaging in hepatocellular carcinoma for identifying cytokeratin 19 status
    Lv, Jing
    Yin, Hongyan
    Yu, Haojun
    Shi, Hongcheng
    ABDOMINAL RADIOLOGY, 2023, 48 (07) : 2331 - 2339
  • [29] Diagnostic performance of 18F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRI
    Hotta, Masatoshi
    Minamimoto, Ryogo
    Yano, Hideaki
    Gohda, Yoshimasa
    Shuno, Yasutaka
    CANCER IMAGING, 2018, 18
  • [30] 18F-FDG PET/CT for Staging and Restaging of Breast Cancer
    Groheux, David
    Cochet, Alexandre
    Humbert, Olivier
    Alberini, Jean-Louis
    Hindie, Elif
    Mankoff, David
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 : 17S - 26S